Single answer
Is Apogee Therapeutics Inc (APGE) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $3.33 or 233.35%
(In 48 weeks 4 days 23 hours and 8 minutes .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Apogee Therapeutics Inc is $91.75, which is $15.99 (21.11%) above the current price today's price.
Low target: $60.00 | High target: $109.00
Company snapshot
A quick overview of the business and its public profile.
Apogee Therapeutics Inc through its subsidiary operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis AD chronic obstructive pulmonary disease COPD and related inflammatory and immunology indications The company primarily develops APG777 a subcutaneous SQ extended halflife monoclonal antibody mAb for AD and APG808 an SQ extended halflife mAb for COPD Its earlierstage programs include APG990 an SQ extended halflife mAb for the treatment of AD and APG222 an extended halflife SQ antibodies for AD The company was founded in 2022 and is based in Waltham Massachusetts
Website: https://www.apogeetherapeutics.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.02. Cash flow to debt ratio: -23.59. Net profit margin: 0.00%. Inflation risk score: medium (0.60/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Apogee Therapeutics Inc is $42.2M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Apogee Therapeutics Inc 10 years ago, but if you had invested on 2023-07-14 when the price was $21.23, you would have made a profit of $54.53 per share or 256.85%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.